These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34060006)

  • 1. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study.
    Kridin K; Schonmann Y; Tzur Bitan D; Damiani G; Peretz A; Weinstein O; Cohen AD
    Am J Clin Dermatol; 2021 Sep; 22(5):709-718. PubMed ID: 34060006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Burden of Coronavirus Disease 2019 and Its Complications in Patients With Atopic Dermatitis-A Nested Case-Control Study.
    Kridin K; Schonmann Y; Tzur Bitan D; Damiani G; Weinstein O; Cohen AD
    Dermatitis; 2021 Oct; 32(1S):S45-S52. PubMed ID: 34138775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience.
    Gisondi P; Piaserico S; Naldi L; Dapavo P; Conti A; Malagoli P; Marzano AV; Bardazzi F; Gasperini M; Cazzaniga S; Costanzo A;
    J Allergy Clin Immunol; 2021 Feb; 147(2):558-560.e1. PubMed ID: 33160968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
    Mahil SK; Dand N; Mason KJ; Yiu ZZN; Tsakok T; Meynell F; Coker B; McAteer H; Moorhead L; Mackenzie T; Rossi MT; Rivera R; Mahe E; Carugno A; Magnano M; Rech G; Balogh EA; Feldman SR; De La Cruz C; Choon SE; Naldi L; Lambert J; Spuls P; Jullien D; Bachelez H; McMahon DE; Freeman EE; Gisondi P; Puig L; Warren RB; Di Meglio P; Langan SM; Capon F; Griffiths CEM; Barker JN; Smith CH;
    J Allergy Clin Immunol; 2021 Jan; 147(1):60-71. PubMed ID: 33075408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
    Izadi Z; Brenner EJ; Mahil SK; Dand N; Yiu ZZN; Yates M; Ungaro RC; Zhang X; Agrawal M; Colombel JF; Gianfrancesco MA; Hyrich KL; Strangfeld A; Carmona L; Mateus EF; Lawson-Tovey S; Klingberg E; Cuomo G; Caprioli M; Cruz-Machado AR; Mazeda Pereira AC; Hasseli R; Pfeil A; Lorenz HM; Hoyer BF; Trupin L; Rush S; Katz P; Schmajuk G; Jacobsohn L; Seet AM; Al Emadi S; Wise L; Gilbert EL; Duarte-García A; Valenzuela-Almada MO; Isnardi CA; Quintana R; Soriano ER; Hsu TY; D'Silva KM; Sparks JA; Patel NJ; Xavier RM; Marques CDL; Kakehasi AM; Flipo RM; Claudepierre P; Cantagrel A; Goupille P; Wallace ZS; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Robinson PC; Machado PM; Griffiths CEM; Barker JN; Smith CH; Yazdany J; Kappelman MD; ;
    JAMA Netw Open; 2021 Oct; 4(10):e2129639. PubMed ID: 34661663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study.
    Talamonti M; Galluzzo M; Chiricozzi A; Quaglino P; Fabbrocini G; Gisondi P; Marzano AV; Potenza C; Conti A; Parodi A; Piaserico S; Bardazzi F; Argenziano G; Rongioletti F; Stingeni L; Micali G; Loconsole F; Rossi MT; Bongiorno MR; Feliciani C; Rubegni P; Amerio P; Fargnoli MC; Pigatto P; Savoia P; Nisticò SP; Giustini S; Carugno A; Cannavo' SP; Rech G; Prignano F; Offidani A; Lombardo M; Zalaudek I; Bianchi L; Peris K; ; Balestri R ; Bernardini N ; Belloni Fortini A ; Burlando M ; Caldarola G ; Campione E ; Cattaneo A ; Dapavo P ; Dastoli S ; De Simone C ; Di Nuzzo S ; Diotallevi F ; Fierro MT ; Franchi C ; Esposito M ; Foti C ; Gambini DM ; Gambardella A ; Girolomoni G ; Giunta A ; Guarneri C ; Gualdi G ; Hansel K ; Megna M ; Mugheddu C ; Musumeci ML ; Patrizi A ; Pellacani G ; Richetta AG ; Rosi E ; Sacchelli L ; Tiberio R ; Tilotta G ; Trovato E ; Venturini M ; Vezzoni R
    Expert Opin Biol Ther; 2021 Feb; 21(2):271-277. PubMed ID: 33216643
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.
    Kridin K; Schonmann Y; Damiani G; Peretz A; Onn E; Bitan DT; Cohen AD
    Dermatol Ther; 2021 Jul; 34(4):e15003. PubMed ID: 34033207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nineteen months into the pandemic, what have we learned about COVID-19-related outcomes in patients with psoriasis?
    Kridin K; Schonmann Y; Onn E; Bitan DT; Weinstein O; Shavit E; Cohen AD
    J Cosmet Dermatol; 2022 Dec; 21(12):6549-6553. PubMed ID: 36056782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of immunosuppressive drugs in immune-mediated inflammatory disease during the coronavirus pandemic.
    Giuliani F; Gualdi G; Amerio P
    Dermatol Ther; 2020 Nov; 33(6):e14204. PubMed ID: 32829511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
    Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
    JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort.
    Reilev M; Kristensen KB; Pottegård A; Lund LC; Hallas J; Ernst MT; Christiansen CF; Sørensen HT; Johansen NB; Brun NC; Voldstedlund M; Støvring H; Thomsen MK; Christensen S; Gubbels S; Krause TG; Mølbak K; Thomsen RW
    Int J Epidemiol; 2020 Oct; 49(5):1468-1481. PubMed ID: 32887982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study.
    Bergman J; Ballin M; Nordström A; Nordström P
    Eur J Epidemiol; 2021 Mar; 36(3):287-298. PubMed ID: 33704634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Clinical Outcomes of 116,539 Patients Hospitalized with COVID-19-Poland, March-December 2020.
    Gujski M; Jankowski M; Rabczenko D; Goryński P; Juszczyk G
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
    Ladda M; Lynde C; Fleming P
    J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting.
    Ghoreishi Amin N; Khosravi S; Atefi N; Seirafianpour F; Farhoodi S; Goodarzi A
    Immun Inflamm Dis; 2023 Nov; 11(11):e1063. PubMed ID: 38018599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study.
    Yousaf A; Gayam S; Feldman S; Zinn Z; Kolodney M
    J Am Acad Dermatol; 2021 Jan; 84(1):70-75. PubMed ID: 32926977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: A retrospective, comparative cohort study.
    Dommasch ED; Lee MP; Joyce CJ; Garry EM; Gagne JJ
    J Am Acad Dermatol; 2018 Dec; 79(6):1061-1068.e1. PubMed ID: 29981385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.
    Erben Y; Franco-Mesa C; Gloviczki P; Stone W; Quinones-Hinojoas A; Meltzer AJ; Lin M; Greenway MRF; Hamid O; Devcic Z; Toskich B; Ritchie C; Lamb CJ; De Martino RR; Siegel J; Farres H; Hakaim AG; Sanghavi DK; Li Y; Rivera C; Moreno-Franco P; O'Keefe NL; Gopal N; Marquez CP; Huang JF; Kalra M; Shields R; Prudencio M; Gendron T; McBane R; Park M; Hoyne JB; Petrucelli L; O'Horo JC; Meschia JF
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1361-1370.e1. PubMed ID: 33836287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and psoriasis: biologic treatment and challenges.
    Ebrahimi A; Sayad B; Rahimi Z
    J Dermatolog Treat; 2022 Mar; 33(2):699-703. PubMed ID: 32598204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.